These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21196254)

  • 61. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
    Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
    Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S
    Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic impact of the putative cancer stem cell markers ABCG2, CD133, ALDH1A1 and CD44V7/8 in metastatic melanoma.
    Speigl L; Janssen N; Weide B; Pawelec G; Shipp C
    Br J Dermatol; 2017 Nov; 177(5):1447-1449. PubMed ID: 27870003
    [No Abstract]   [Full Text] [Related]  

  • 66. Cytometric profiling of CD133+ cells in human colon 
carcinoma cell lines identifies a common core phenotype 
and cell type-specific mosaics.
    Gemei M; Di Noto R; Mirabelli P; Del Vecchio L
    Int J Biol Markers; 2013 Sep; 28(3):267-73. PubMed ID: 23709346
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.
    Steg AD; Bevis KS; Katre AA; Ziebarth A; Dobbin ZC; Alvarez RD; Zhang K; Conner M; Landen CN
    Clin Cancer Res; 2012 Feb; 18(3):869-81. PubMed ID: 22142828
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.
    Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA
    Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.
    Nagata H; Ishihara S; Kishikawa J; Sonoda H; Murono K; Emoto S; Kaneko M; Sasaki K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Kawai K; Nozawa H
    Int J Oncol; 2018 Mar; 52(3):721-732. PubMed ID: 29328371
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hes1 is involved in the self-renewal and tumourigenicity of stem-like cancer cells in colon cancer.
    Gao F; Zhang Y; Wang S; Liu Y; Zheng L; Yang J; Huang W; Ye Y; Luo W; Xiao D
    Sci Rep; 2014 Feb; 4():3963. PubMed ID: 24492635
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.
    Marquardt JU; Factor VM; Thorgeirsson SS
    J Hepatol; 2010 Sep; 53(3):568-77. PubMed ID: 20646772
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cancer stem cell markers in breast neoplasias: their relevance and distribution in distinct molecular subtypes.
    Schmitt F; Ricardo S; Vieira AF; Dionísio MR; Paredes J
    Virchows Arch; 2012 Jun; 460(6):545-53. PubMed ID: 22562130
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma.
    Choi D; Lee HW; Hur KY; Kim JJ; Park GS; Jang SH; Song YS; Jang KS; Paik SS
    World J Gastroenterol; 2009 May; 15(18):2258-64. PubMed ID: 19437567
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
    Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
    Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High expression of cancer stem cell markers in cholangiolocellular carcinoma.
    Iwahashi S; Utsunomiya T; Shimada M; Saito Y; Morine Y; Imura S; Ikemoto T; Mori H; Hanaoka J; Bando Y
    Surg Today; 2013 Jun; 43(6):654-60. PubMed ID: 23192764
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
    Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
    Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.
    O'Brien CA; Pollett A; Gallinger S; Dick JE
    Nature; 2007 Jan; 445(7123):106-10. PubMed ID: 17122772
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression of gastrin precursors by CD133-positive colorectal cancer cells is crucial for tumour growth.
    Ferrand A; Sandrin MS; Shulkes A; Baldwin GS
    Biochim Biophys Acta; 2009 Mar; 1793(3):477-88. PubMed ID: 19321126
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biology and clinical implications of CD133(+) liver cancer stem cells.
    Ma S
    Exp Cell Res; 2013 Jan; 319(2):126-32. PubMed ID: 22999864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.